Press Releases Items Per Page 102550 Year None20212020201920182017201620152014 11-10-2021 Daré Bioscience Reports Third Quarter 2021 Financial Results and Provides a Company Update 11-09-2021 Daré Bioscience to Present at the Stifel 2021 Virtual Healthcare Conference 11-03-2021 Daré Bioscience to Host Third Quarter 2021 Financial Results and Company Update Conference Call and Webcast on November 10, 2021 10-06-2021 Daré Bioscience to Participate in Panel Discussion at DTC Perspectives’ Xpectives.Health Summit, October 12-14, 2021 09-27-2021 Daré Bioscience Announces NIH Grant Award to Support Development of DARE-LARC1 09-23-2021 Daré Bioscience Initiates Phase 1/2 Clinical Study of DARE-VVA1, Intravaginal Tamoxifen for the Treatment of Vulvar and Vaginal Atrophy 09-22-2021 Daré Bioscience to Present at the 2021 Cantor Virtual Global Healthcare Conference 09-08-2021 Daré Bioscience to Participate in H.C. Wainwright 23rd Annual Global Investment Conference 09-07-2021 Daré Bioscience to Participate in Panel Discussion at Women’s Health Innovation Summit 09-01-2021 Daré Bioscience to Present at the 13th European Congress on Menopause and Andropause Pagination Current page 1 Page 2 Page 3 Page 4 Next page next › Last page last » Displaying 1 - 10 of 33
11-10-2021 Daré Bioscience Reports Third Quarter 2021 Financial Results and Provides a Company Update
11-03-2021 Daré Bioscience to Host Third Quarter 2021 Financial Results and Company Update Conference Call and Webcast on November 10, 2021
10-06-2021 Daré Bioscience to Participate in Panel Discussion at DTC Perspectives’ Xpectives.Health Summit, October 12-14, 2021
09-23-2021 Daré Bioscience Initiates Phase 1/2 Clinical Study of DARE-VVA1, Intravaginal Tamoxifen for the Treatment of Vulvar and Vaginal Atrophy
09-08-2021 Daré Bioscience to Participate in H.C. Wainwright 23rd Annual Global Investment Conference
